Human growth hormone: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
No edit summary |
||
| Line 154: | Line 154: | ||
== References == | == References == | ||
<references/> | <references/> | ||
*12. ANDERSON, Lloyd (2012). Nanobiology and physiology of growth hormone secretion. Experimental Biology and Medicine. Experimental biology and medicine. https://doi.org/10.1258/ebm.2011.011306 | |||
*13. Clarence J. Gibbs, Jr., Ph.D., Anthony Joy, D.O., Reid Heffner, M.D., Maryellen Franko, Ph.D., Masayuki Miyazaki, M.D., David M. Asher, M.D., Joseph E. Parisi, M.D., Paul W. Brown, M.D., and D. Carleton Gajdusek, M.D. (1985). Clinical and Pathological Features and Laboratory Confirmation of Creutzfeldt–Jakob Disease in a Recipient of Pituitary-Derived Human Growth Hormone. The New England Journal of Medicine. https://www.nejm.org/doi/pdf/10.1056/NEJM198509193131207 | |||
*14. Orthopedic Institute for Children. Turner Syndrome. Consulted on January 2022. URL : https://www.ortho-institute.org/patient-care/orthopedic-specialties/skeletal-dysplasia-dwarfism/turner-syndrome/ | |||
==See Also== | ==See Also== | ||
* [[Hormone]] | * [[Hormone]] | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||